Moderna COVID-19 mRNA vaccine procurement: ~$8.2B — a contract the Army handled ("defense procurement network × public health") (USAspending)
Per USAspending, the U.S. Army (Army Contracting Command) handled the procurement contract for the COVID-19 mRNA vaccine "mRNA-1273" (Moderna). The description reads "100M doses"; the value is about $8.2 billion ($8,204,906,278), a definitive contract running August 2020–August 2023. It is a case in which the Department of Defense's procurement network was mobilized not only for weapons but for public health during the pandemic.
Contract key facts
- RecipientMODERNATX, INC.
- Contract value$8,204,906,278 (≈$8.2B)
- BranchArmy
- Awarding agencyDepartment of Defense
- Awarding sub-agencyDepartment of the Army
- Award typeDEFINITIVE CONTRACT
- Period of performance2020-08-11 〜 2023-08-10
- Contract ID (PIID)W911QY20C0100
Contract scope (original)
100M SARS-COV-2 MRNA-1273 VACCINE DOSES
Key points
- The Army (Army Contracting Command) handled procurement of Moderna's COVID-19 mRNA vaccine "mRNA-1273." Cumulative ~$8.2B ($8,204,906,278).
- The description reads "100M doses." Definitive contract, performance August 11, 2020 – August 10, 2023.
- Part of the cross-government "Operation Warp Speed" — the DoD procurement/logistics network used for public health.
- The cumulative value exceeding the 100M-dose baseline owes to large contracts accumulating via multi-year modifications.
- Shows the breadth of "defense spending" — national public-health outlays sitting alongside weapons in primary data.
That this contract appears in "defense data" takes a bit of explaining. The recipient is the pharmaceutical company Moderna and the subject is the COVID-19 mRNA vaccine "mRNA-1273," but the awarding party is the U.S. Army's procurement organization (Army Contracting Command).
In 2020, under "Operation Warp Speed," the cross-government effort to rapidly accelerate vaccine development and production against the pandemic, the Department of Defense lent its own vast procurement and logistics apparatus and handled the practical work of large-scale vaccine procurement. The same contracting machinery that buys weapons worked, during the pandemic, for public health — this entry is emblematic of that.
The amount requires care to read. The description says "100M doses," yet the contract value reaches about $8.2 billion cumulatively. This owes to the nature of large government contracts accumulating through modifications over many years.
Starting from an initial quantity, additional procurements pile up and the cumulative figure swells — the same accumulation often seen in defense contracts occurred here in vaccine procurement (this site does not fill in specific added quantities beyond the description).
What this single entry teaches is the breadth of the category "defense spending." USAspending's defense category holds, alongside fighters and missiles, a vast vaccine procurement poured into a national public-health emergency. Reading spending data as a primary source across categories reveals moments when the "DoD procurement network" functioned as infrastructure for society as a whole, beyond peacetime assumptions.
Why it matters
This is primary data showing the DoD procurement network can be mobilized for something other than weapons — a national public-health emergency. Reading spending data across categories reveals that the "defense spending" bucket encompasses broader societal functions than assumed. For readers tracking the government-procurement market, the health industry, and pandemic response, it helps gauge the scale of the defense × public-health intersection.
FAQ
What data is this?
Is the amount final?
Why is a vaccine contract in defense data?
Sources (primary)
This article is an independent organization based on the U.S. official spending data below. Verify the exact, latest details with the official source.
- USAspending (award details)
- Contract ID (PIID)：W911QY20C0100